3 European Projects Found
Searched on 125080 European Projects
FINISHED
A BLUEPRINT of Haematopoietic Epigenomes (BLUEPRINT)
Start date: Oct 1, 2011, End date: Sep 30, 2016,
In response to the call for a high impact initiative on the human epigenome, the BLUEPRINT Consortium has been formed with the aim of generating at least 100 reference epigenomes and studying them to advance and exploit knowledge of the underlying biological processes and mechanisms in health and disease. BLUEPRINT will focus on distinct types of haematopoietic cells from healthy individuals and o ...
Read Project
45
Partners Participants
FINISHED
Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance (OVER-MYR)
Start date: Jan 1, 2012, End date: Jun 30, 2015,
Multiple Myeloma (MM) is a currently incurable rare malignant plasma cell disease, which invariably relapses despite therapy. The objective of OVER-MYR is to understand the causes of drug resistance and relapse, develop novel strategies to overcome these, provide proof of principal for phase I/II trial, and thus impact on MM-patient’s survival.Currently-used drugs target both MM cells (MMC) and c ...
Read Project
11
Partners Participants
FINISHED
Open Collaborative Model for Tuberculosis Lead Optimisation (ORCHID)
Start date: Jan 1, 2011, End date: Jun 30, 2015,
"Early stage Drug Discovery efforts over the last 5 years have resulted in the identification of a number of promising lead compounds in the fight against TB. These leads need to be further progressed and optimised into candidates for pre-clinical development through the Drug Development progression cascade.Three compound families are of particular interest: 1) InhA Inhibitors, 2) New potent whole ...
Read Project
